News
21h
The Healthy @Reader's Digest on MSNDo GLP-1 Patches Work? An Expert Doctor Weighs In with the Verdict
Dr. Bhuyan serves on the boards of both Planned Parenthood Federation of America and Planned Parenthood Global. Her areas of ...
9h
Everyday Health on MSNFDA Raises Safety Concerns About Compounded GLP-1 Weight Loss Drugs
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
1d
MedPage Today on MSNNew Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs
No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) ...
7h
News-Medical.Net on MSNGIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...
Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...
In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...
1d
Medpage Today on MSNGLP-1 Drugs May Hold Benefit in Painful Skin Disease
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results